These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28255881)

  • 1. Novel HPLC-Based Screening Method to Assess Developability of Antibody-Like Molecules.
    Kohli N; Geddie ML
    Methods Mol Biol; 2017; 1575():189-196. PubMed ID: 28255881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel screening method to assess developability of antibody-like molecules.
    Kohli N; Jain N; Geddie ML; Razlog M; Xu L; Lugovskoy AA
    MAbs; 2015; 7(4):752-8. PubMed ID: 25961854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An accelerated surface-mediated stress assay of antibody instability for developability studies.
    Kopp MRG; Wolf Pérez AM; Zucca MV; Capasso Palmiero U; Friedrichsen B; Lorenzen N; Arosio P
    MAbs; 2020; 12(1):1815995. PubMed ID: 32954930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early developability screen of therapeutic antibody candidates using Taylor dispersion analysis and UV area imaging detection.
    Lavoisier A; Schlaeppi JM
    MAbs; 2015; 7(1):77-83. PubMed ID: 25514497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Antibody Developability Profiles Through Early Stage Discovery Screening.
    Bailly M; Mieczkowski C; Juan V; Metwally E; Tomazela D; Baker J; Uchida M; Kofman E; Raoufi F; Motlagh S; Yu Y; Park J; Raghava S; Welsh J; Rauscher M; Raghunathan G; Hsieh M; Chen YL; Nguyen HT; Nguyen N; Cipriano D; Fayadat-Dilman L
    MAbs; 2020; 12(1):1743053. PubMed ID: 32249670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating effects of sample pretreatment on protein stability using size-exclusion chromatography and high-resolution continuum source atomic absorption spectrometry.
    Rakow T; El Deeb S; Hahne T; El-Hady DA; AlBishri HM; Wätzig H
    J Sep Sci; 2014 Sep; 37(18):2583-90. PubMed ID: 24964383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separating clinical antibodies from repertoire antibodies, a path to in silico developability assessment.
    Negron C; Fang J; McPherson MJ; Stine WB; McCluskey AJ
    MAbs; 2022; 14(1):2080628. PubMed ID: 35771588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy.
    Liu Y; Caffry I; Wu J; Geng SB; Jain T; Sun T; Reid F; Cao Y; Estep P; Yu Y; Vásquez M; Tessier PM; Xu Y
    MAbs; 2014; 6(2):483-92. PubMed ID: 24492294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening of antibody variants for chemical stability: identification of deamidation-resistant mutants.
    DiCara DM; Andersen N; Chan R; Ernst JA; Ayalon G; Lazar GA; Agard NJ; Hilderbrand A; Hötzel I
    MAbs; 2018 Oct; 10(7):1073-1083. PubMed ID: 30130444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The design and characterization of oligospecific antibodies for simultaneous targeting of multiple disease mediators.
    Dimasi N; Gao C; Fleming R; Woods RM; Yao XT; Shirinian L; Kiener PA; Wu H
    J Mol Biol; 2009 Oct; 393(3):672-92. PubMed ID: 19699208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Therapeutic Antibody Developability by Combinations of In Vitro and In Silico Methods.
    Wolf Pérez AM; Lorenzen N; Vendruscolo M; Sormanni P
    Methods Mol Biol; 2022; 2313():57-113. PubMed ID: 34478132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High throughput cross-interaction measures for human IgG1 antibodies correlate with clearance rates in mice.
    Kelly RL; Sun T; Jain T; Caffry I; Yu Y; Cao Y; Lynaugh H; Brown M; Vásquez M; Wittrup KD; Xu Y
    MAbs; 2015; 7(4):770-7. PubMed ID: 26047159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation risk prediction for antibodies and its application to biotherapeutic development.
    Obrezanova O; Arnell A; de la Cuesta RG; Berthelot ME; Gallagher TR; Zurdo J; Stallwood Y
    MAbs; 2015; 7(2):352-63. PubMed ID: 25760769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developability assessment during the selection of novel therapeutic antibodies.
    Jarasch A; Koll H; Regula JT; Bader M; Papadimitriou A; Kettenberger H
    J Pharm Sci; 2015 Jun; 104(6):1885-1898. PubMed ID: 25821140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between Dynamic Light Scattering and Size Exclusion High Performance Liquid Chromatography for Monitoring the Effect of pH on Stability of Biopharmaceuticals.
    Al-Ghobashy MA; Mostafa MM; Abed HS; Fathalla FA; Salem MY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():1-9. PubMed ID: 28578190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in silico assessment of the developability of a designed monoclonal antibody library.
    Wolf Pérez AM; Sormanni P; Andersen JS; Sakhnini LI; Rodriguez-Leon I; Bjelke JR; Gajhede AJ; De Maria L; Otzen DE; Vendruscolo M; Lorenzen N
    MAbs; 2019; 11(2):388-400. PubMed ID: 30523762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics.
    Khetan R; Curtis R; Deane CM; Hadsund JT; Kar U; Krawczyk K; Kuroda D; Robinson SA; Sormanni P; Tsumoto K; Warwicker J; Martin ACR
    MAbs; 2022; 14(1):2020082. PubMed ID: 35104168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of affinity adsorption chromatography for the purification of human brain specific antibodies.
    Tripatzis I; Warecka K; Wong MC
    Nat New Biol; 1971 Apr; 230(16):250-1. PubMed ID: 5280407
    [No Abstract]   [Full Text] [Related]  

  • 19. Developability assessment for monoclonal antibody drug candidates: a case study.
    Garripelli VK; Wu Z; Gupta S
    Pharm Dev Technol; 2021 Jan; 26(1):11-20. PubMed ID: 32986499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine as an eluent for automated on-line Protein A/size exclusion chromatographic analysis of monoclonal antibody aggregates in cell culture.
    Wang S; Raghani A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 945-946():115-20. PubMed ID: 24333642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.